GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Notes Receivable

Q2M Biotech AG (HAM:QBI) Notes Receivable : €0.00 Mil (As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Notes Receivable?

Q2M Biotech AG's Notes Receivable for the quarter that ended in . 20 was €0.00 Mil.


Q2M Biotech AG Notes Receivable Historical Data

The historical data trend for Q2M Biotech AG's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Notes Receivable Chart

Q2M Biotech AG Annual Data
Trend
Notes Receivable

Q2M Biotech AG Quarterly Data
Notes Receivable

Q2M Biotech AG Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Q2M Biotech AG Notes Receivable Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines